Compare GHG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
| Metric | GHG | SEER |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.9M | 113.0M |
| IPO Year | 2017 | 2020 |
| Metric | GHG | SEER |
|---|---|---|
| Price | $0.97 | $1.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 34.0K | ★ 265.3K |
| Earning Date | 08-24-2026 | 11-10-2026 |
| Dividend Yield | ★ 6.04% | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | $56.17 | N/A |
| Revenue Next Year | N/A | $20.50 |
| P/E Ratio | $5.76 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $0.91 | $1.55 |
| 52 Week High | $2.10 | $2.39 |
| Indicator | GHG | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 49.69 | 43.10 |
| Support Level | $0.99 | $1.81 |
| Resistance Level | $1.14 | $2.09 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 45.00 | 7.14 |
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.